Anchit Bhagat
My research focuses on lung cancer driven by mutations in EGFR. Specifically, I am investigating the resistance mechanisms to tyrosine kinase inhibitors(TKI) and immune checkpoint inhibitors(ICI) in this type of cancer and finding a way to overcome these resistance mechanisms for better treatment outcomes. I am working with a novel mouse model that has been designed to express several EGFR mutations that are resistant to TKIs and ICIs as well as expressing several reporter genes.
